SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanjivani Paranteral informs about newspaper publication

23 Oct 2023 Evaluate
Pursuant to Regulation 30 and 47 read with Schedule Ill of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Sanjivani Paranteral has enclosed copy of newspaper publication in the following newspapers on 19th October 2023 with respect to Un-Audited Financial Results for the quarter ended September 30, 2023 approved at the meeting of Board of Directors held on October 18, 2023: Financial Express, Prathakal.

The above information is a part of company’s filings submitted to BSE.

Sanjivani Paranteral Share Price

176.00 3.25 (1.88%)
21-Apr-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.70
Dr. Reddys Lab 1220.00
Cipla 1232.60
Zydus Lifesciences 928.05
Lupin 2305.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×